Editor's Note
In its process for issuing a new recommendation on screening for obstructive sleep apnea (OSA) in asymptomatic adults or adults with unrecognized symptoms, the US Preventive Services Task Force (USPSTF) found insufficient evidence on screening for or treatment of OSA.
The USPSTF concluded that the current evidence is insufficient to assess the balance of benefits and harms of OSA screening in this population.
Importance Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10% for mild OSA and 3.8% to 6.5% for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity.
Read More >>The US Food and Drug Administration receives more than 100,000…
Each year, there are more studies raising concerns about infections…
Health systems across the country are enacting COVID-19 mandates to…